Veryst is proud to have supported 3D BioLabs LLC with a study described in its recent publication titled “Rodent Model for Orthotopic Implantation of Engineered Liver Devices.” The publication presents a novel surgical technique to provide blood supply to implanted cellularized devices that augment or replace liver tissue function.